Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery
Latest Information Update: 01 Nov 2022
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus First in man; Pharmacokinetics
- Sponsors Cali Pharmaceuticals
Most Recent Events
- 26 Oct 2022 According to a Cali Biosciences media release, data published in a peer-reviewed medical journal, Japan Journal of Medicine.
- 19 Nov 2021 According Cali Biosciences media release, results of this study presented at the 20th Annual American Society of Regional Anesthesia and Pain Medicine (ASRA) Meeting.
- 05 Jun 2020 Status changed from not yet recruiting to completed.